Benzinga's Top Initiations - Intl Flavors & Fragrances (NYSE:IFF), Delta Air Lines (NYSE:DAL)

Analysts at JMP Securities initiated coverage on Myovant Sciences Ltd MYOV with a Market Outperform rating. The price target for Myovant Sciences is set to $23. Myovant Sciences shares closed at $11.25 on Friday.
Analysts at Brean Capital initiated coverage on Netflix, Inc. NFLX with a Buy rating. The price target for Netflix is set to $145. Netflix shares closed at $115.21 on Friday.
Analysts at Goldman Sachs initiated coverage of International Flavors & Fragrances Inc IFF with a Neutral rating. The price target for International Flavors & Fragrances is set to $121.50. International Flavors & Fragrances shares closed at $119.78 on Friday.
Analysts at SunTrust Robinson Humphrey initiated coverage on Ra Pharmaceuticals Inc RARX with a Buy rating. The price target for Ra Pharmaceuticals is set to $32. Ra Pharmaceuticals shares closed at $13.29 on Friday.
Morgan Stanley initiated coverage on ZTO Express (Cayman) Inc (ADR) ZTO with a Overweight rating. The price target for ZTO Express is set to $20. ZTO Express shares closed at $16.30 on Friday.
Analysts at Cowen & Co initiated coverage on Sito Mobile Ltd SITO with a Outperform rating. The price target for Sito Mobile is set to $6. Sito Mobile shares closed at $3.92 on Friday.
Analysts at Barclays initiated coverage on Myovant Sciences Ltd MYOV with a Overweight rating. The price target for Myovant Sciences is set to $18. Myovant Sciences shares closed at $11.25 on Friday.
Analysts at Stifel Nicolaus initiated coverage on Teekay LNG Partners L.P. TGP with a Hold rating. The price target for Teekay LNG Partners is set to $14.50. Teekay LNG Partners shares closed at $14.05 on Friday.
Credit Suisse initiated coverage on > Ra Pharmaceuticals Inc RARX with a Outperform rating. The price target for Ra Pharmaceuticals is set to $19. Ra Pharmaceuticals shares closed at $13.29 on Friday.
H.C. Wainwright initiated coverage on Kite Pharma Inc KITE with a Buy rating. The price target for Kite Pharma is set to $78. Kite Pharma shares closed at $51.80 on Friday.

Market News and Data brought to you by Benzinga APIs